CGS-CIMB Research has maintained its ‘add’ rating for China Sunsine Chemical Holdings with a higher target price of 61 cents from 55 cents previously due to an upward trend in average selling prices (ASPs).

This comes following China Sunsine’s “solid set of results” for the 2HFY2020. The company’s earnings of RMB 136 million ($234 million) for the period were in line with analyst Ong Khang Chuen’s expectations and up 11% y-o-y on the back of higher revenue from better ASPs.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook